• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

W150A突变型凝集素样氧化低密度脂蛋白受体1(LOX-1)与氧化型低密度脂蛋白(OxLDL)结合受损的结构影响

Structural implication for the impaired binding of W150A mutant LOX-1 to oxidized low density lipoprotein, OxLDL.

作者信息

Nakano Shogo, Sugihara Mamoru, Yamada Risato, Katayanagi Katsuo, Tate Shin-ichi

机构信息

Department of Mathematical and Life Sciences, Hiroshima University, Higashi-Hiroshima, Japan.

出版信息

Biochim Biophys Acta. 2012 May;1824(5):739-49. doi: 10.1016/j.bbapap.2012.02.003. Epub 2012 Feb 18.

DOI:10.1016/j.bbapap.2012.02.003
PMID:22369967
Abstract

Lectin-like oxidized lipoprotein (OxLDL) receptor 1, LOX-1, is the major OxLDL receptor expressed on vascular endothelial cells. We have previously reported the ligand-recognition mode of LOX-1 based on the crystal structure of the ligand binding domain (C-type lectin-like domain, CTLD) and surface plasmon resonance analysis, which suggested that the functional significance of the CTLD dimer (the 'canonical' dimer) is to harbor the characteristic "basic spine" on its surface. In this study, we have identified the key inter-domain interactions in retaining the canonical CTLD dimer by X-ray structural analysis of the inactive mutant W150A CTLD. The canonical CTLD dimer forms through tight hydrophobic interactions, in which W150 engages in a lock-and-key manner and represents the main interaction. The loss of the Trp ring by mutation to Ala prevents the formation of the canonical dimer, as elucidated from docking calculations using the crystal structure of W150A CTLD. The results emphasize that the canonically formed CTLD dimer is essential for LOX-1 to bind to OxLDL, which supports our proposed view that the basic spine surface present in the correctly formed dimer plays a primal role in OxLDL recognition. This concept provides insight into the pathogenic pattern recognized by LOX-1 as a member of the pattern recognition receptors.

摘要

凝集素样氧化型低密度脂蛋白(OxLDL)受体1(LOX-1)是血管内皮细胞上表达的主要OxLDL受体。我们之前基于配体结合结构域(C型凝集素样结构域,CTLD)的晶体结构和表面等离子体共振分析报道了LOX-1的配体识别模式,这表明CTLD二聚体(“经典”二聚体)的功能意义在于在其表面容纳特征性的“碱性脊柱”。在本研究中,我们通过对无活性突变体W150A CTLD进行X射线结构分析,确定了维持经典CTLD二聚体的关键结构域间相互作用。经典CTLD二聚体通过紧密的疏水相互作用形成,其中W150以锁钥方式参与并代表主要相互作用。从使用W150A CTLD晶体结构的对接计算可以看出,突变为丙氨酸导致色氨酸环缺失,从而阻止了经典二聚体的形成。结果强调,经典形成的CTLD二聚体对于LOX-1结合OxLDL至关重要,这支持了我们提出的观点,即正确形成的二聚体中存在的碱性脊柱表面在OxLDL识别中起主要作用。这一概念为理解LOX-1作为模式识别受体成员所识别的致病模式提供了见解。

相似文献

1
Structural implication for the impaired binding of W150A mutant LOX-1 to oxidized low density lipoprotein, OxLDL.W150A突变型凝集素样氧化低密度脂蛋白受体1(LOX-1)与氧化型低密度脂蛋白(OxLDL)结合受损的结构影响
Biochim Biophys Acta. 2012 May;1824(5):739-49. doi: 10.1016/j.bbapap.2012.02.003. Epub 2012 Feb 18.
2
Surface plasmon resonance study on functional significance of clustered organization of lectin-like oxidized LDL receptor (LOX-1).凝集素样氧化型低密度脂蛋白受体(LOX-1)簇状组织功能意义的表面等离子体共振研究
Biochim Biophys Acta. 2011 Feb;1814(2):345-54. doi: 10.1016/j.bbapap.2010.10.006. Epub 2010 Oct 28.
3
Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL.人凝集素样氧化型低密度脂蛋白受体1配体结合域的晶体结构及其对氧化型低密度脂蛋白的配体识别模式
Structure. 2005 Jun;13(6):905-17. doi: 10.1016/j.str.2005.03.016.
4
Molecular mechanism of statin-mediated LOX-1 inhibition.他汀类药物介导的凝集素样氧化低密度脂蛋白受体-1(LOX-1)抑制的分子机制。
Cell Cycle. 2015;14(10):1583-95. doi: 10.1080/15384101.2015.1026486.
5
Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant.
BMC Struct Biol. 2007 Nov 7;7:73. doi: 10.1186/1472-6807-7-73.
6
Chimeric structural stabilities in the coiled-coil structure of the NECK domain in human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).人凝集素样氧化型低密度脂蛋白受体1(LOX-1)颈部结构域卷曲螺旋结构中的嵌合结构稳定性。
J Biochem. 2007 Jun;141(6):855-66. doi: 10.1093/jb/mvm093. Epub 2007 Apr 6.
7
Refolding and characterization of the functional ligand-binding domain of human lectin-like oxidized LDL receptor.
Protein Expr Purif. 2003 Nov;32(1):68-74. doi: 10.1016/S1046-5928(03)00220-1.
8
Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein.凝集素样氧化型低密度脂蛋白受体1(LOX-1)的凝集素样结构域内碱性氨基酸残基对氧化型低密度脂蛋白结合的要求
FEBS Lett. 2001 Jun 22;499(3):215-9. doi: 10.1016/s0014-5793(01)02557-1.
9
Oligomerization is required for the activity of recombinant soluble LOX-1.重组可溶性LOX-1的活性需要寡聚化。
FEBS J. 2009 Sep;276(17):4909-20. doi: 10.1111/j.1742-4658.2009.07190.x. Epub 2009 Jul 31.
10
Purification, crystallization and preliminary X-ray analysis of the ligand-binding domain of human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1).人凝集素样氧化型低密度脂蛋白受体1(LOX-1)配体结合域的纯化、结晶及初步X射线分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2005 May 1;61(Pt 5):524-7. doi: 10.1107/S1744309105012042. Epub 2005 Apr 28.

引用本文的文献

1
Mutation within the transmembrane domain of oxidized low-density lipoprotein receptor 1 influences oxidized low-density lipoprotein-induced signal transduction.氧化型低密度脂蛋白受体1跨膜结构域内的突变影响氧化型低密度脂蛋白诱导的信号转导。
Innate Immun. 2025 Jan-Dec;31:17534259251350447. doi: 10.1177/17534259251350447. Epub 2025 Jun 16.
2
A small-molecule inhibitor of lectin-like oxidized LDL receptor-1 acts by stabilizing an inactive receptor tetramer state.凝集素样氧化型低密度脂蛋白受体-1的小分子抑制剂通过稳定无活性的受体四聚体状态发挥作用。
Commun Chem. 2020 Jun 10;3(1):75. doi: 10.1038/s42004-020-0321-2.
3
Loxin Reduced the Inflammatory Response in the Liver and the Aortic Fatty Streak Formation in Mice Fed with a High-Fat Diet.
洛辛可降低高脂饮食喂养小鼠肝脏的炎症反应和主动脉脂肪条纹形成。
Int J Mol Sci. 2022 Jun 30;23(13):7329. doi: 10.3390/ijms23137329.
4
Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs.高级糖基化终产物(AGEs):形成、化学、分类、受体以及与 AGEs 相关的疾病。
Cells. 2022 Apr 12;11(8):1312. doi: 10.3390/cells11081312.